
Mario E. Lacouture, MD
Dermatologist
Titles
Director, Oncodermatology Program; Research Director, Dermatology Service
Clinical Expertise
Dermatologic Side Effects of Cancer Treatment
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Lacouture accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-608-2337 Office Phone
- Speaks English, Italian, and Spanish

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, Javeriana University
Residencies
Dermatology - University of Chicago
Fellowships
Brigham and Women's Hospital
Board Certifications
Dermatology
I am a board-certified dermatologist and have dedicated my entire career exclusively to the care of skin, hair, and nail conditions in people living with cancer. I created the first clinical program in oncodermatology in 2006 in Chicago, and since joining Memorial Sloan Kettering Cancer Center in 2009, I have had the privilege of working with colleagues across many disciplines, including medical oncology, surgery, and radiation therapy, with the goal of optimizing cancer care by preventing and treating skin conditions that occur during or after cancer treatments.
Read more
The treatment of cancer has evolved dramatically over the past few decades, and current therapies are generally more effective than what was available before. Despite these remarkable advances, one of the consequences of chemotherapy, surgery, or radiation has been the appearance of side effects that target the skin, hair, or nails. Side effects can be very distressing when they are visible to others and in some cases can impact one’s sense of self or relationships with friends, family, and colleagues. Sometimes, these side effects are associated with symptoms such as itching or pain, which may impair one’s motility and ability to perform everyday tasks. There might also be side effects in the skin or nails that can affect overall health — in these cases, it is very important that they are treated effectively so patients can continue receiving cancer therapy. Close communication with treating oncologists ensures that interventions against side effects do not interfere with the effectiveness of cancer treatments.
Since oncodermatology is an emerging field and new cancer treatments and associated side effects are constantly evolving, research and education are vital components of my work. I am leading clinical trials to better understand, as well as prevent or treat, both short- and long-term side effects of treatment. Through collaborations with oncologists and laboratory scientists, I have published more than 280 scientific articles and books, with the ultimate goal of advancing cancer care through dermatologic health.
Awards and Honors
- Castle Connolly: America's Top Doctors (2023)
- Everett C Fox Memorial Award, American Academy of Dermatology (2021)
- Larry Kun Memorial Award, Pediatric Brain Tumor Consortium (2018)
- Sabine Kohler Award, International Society of Dermatopathology (2017)
- Castle Connolly: New York Magazine Top Doctors (2014-2021)
- Physician of the Year Award, CancerCare, New York (2012)
- Louise and Allston Boyer Young Investigator Award-Memorial Sloan-Kettering (2012)
- Career Development Award, Dermatology Foundation (2008)
- Zell Scholarship, Robert H. Lurie Comprehensive Cancer Center (2006)
- Kligman Fellowship, Society for Investigative Dermatology (2005)
- Henry W. Menn Memorial Award, The Skin Cancer Foundation (2004)
- Charles B. Huggins Lectureship, The University of Chicago (2004)
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Lacouture
- A Phase II Study of Benralizumab in People with Rash or Itching Caused by Immunotherapies or Targeted Cancer Treatments
- A Phase II Study of Clindamycin and Triamcinolone in People with Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
- A Phase II Study of LUT014 in People with Acneiform Rash from Colorectal Cancer Treatment
- A Phase II Study of OQL011 in People with Hand-Foot Skin Reaction as a Result of Targeted Cancer Treatments
Read more
- A Phase II Study of Rituximab or Tocilizumab to Treat Side Effects After Cancer Immunotherapy that Require Prolonged Steroid Treatment
- A Study Assessing Quality of Life in People with Skin Conditions Due to Cancer or Its Treatment
- A Study of Oral Minoxidil to Treat Hair Loss in Children and Teens Who Are Cancer Survivors
- A Study to Learn More About Skin Reactions to Cancer Immunotherapy
- Clinical Trials Co-Investigated by Dr. Lacouture
- A Phase II Study of Oleogel-S10 Gel to Treat Skin Irritation from Radiation Therapy for Breast Cancer

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Lacouture’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Mario E. Lacouture discloses the following relationships and financial interests:
-
Adgero Biopharmaceuticals Inc
Provision of Services -
American Academy of Dermatology
Provision of Services -
American Society of Pediatric Hematology/Oncology (ASPHO)
Provision of Services -
Apricity Health
Ownership / Equity Interests; Provision of Services -
AstraZeneca
Provision of Services -
Atlantic Canada Oncology Group
Provision of Services -
BGB Communications LLC
Provision of Services -
Bicara Therapeutics, Inc.
Provision of Services -
Deciphera
Provision of Services -
DelMar Pharmaceuticals, Inc.
Provision of Services -
EMD Serono, Inc
Provision of Services -
GCO Global
Provision of Services -
Hoth Therapeutics, Inc.
Provision of Services -
Incyte
Provision of Services -
Innovaderm Research Inc.
Provision of Services -
John Wiley & Sons, Inc.
Intellectual Property Rights -
Johnson & Johnson
Provision of Services -
La Fonderie Ressources
Provision of Services -
La Roche-Posay
Provision of Services -
Loxo Oncology
Provision of Services -
Lutris Pharma Ltd.
Provision of Services -
MJH Life Sciences
Provision of Services
-
Michigan Dermatological Society
Provision of Services -
NKMax America, Inc.
Provision of Services -
NanOlogy LLC
Provision of Services -
Novartis
Provision of Services -
Novartis Pharmaceuticals Corporation
Provision of Services -
Novocure
Provision of Services -
OnQuality Pharmaceuticals Ltd.
Provision of Services -
Oncoderm LLC
Provision of Services (uncompensated) -
Patient Resource LLC
Provision of Services -
QED Therapeutics, Inc.
Provision of Services -
RBC Consulting
Provision of Services -
RMEI Medical Education, LLC
Provision of Services -
Society for Immunotherapy of Cancer
Provision of Services -
Takeda Millennium
Provision of Services -
Taylor & Francis Group
Intellectual Property Rights -
The Lynx Group, LLC
Provision of Services -
Tyra Biosciences, Inc.
Provision of Services -
Varsona Pharmaceuticals, LLC
Provision of Services -
WebMD
Provision of Services -
Wolters Kluwer
Provision of Services -
eSquared Communication Consulting
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].